Parallel Practices: A Nurse Practitioner's Perspective on Hospital vs. Frontline Doctor Protocols - TribPapers

Parallel Practices: A Nurse Practitioner’s Perspective on Hospital vs. Frontline Doctor Protocols

Nurse Practitioner Staci Kay of North Carolina Physicians for Freedom. Photo submitted.

Asheville – Ever since the first hospitalizations for the coronavirus, or COVID-19, there has seemed to be a tug-of-war between politicians/bureaucrats, and the medical professionals who’ve actually been caring for the patients on the front lines. These medical professionals began speaking out, trying to make the public aware of things being done with patients that didn’t go along with good medical practices that have been in place for years.

Most of the concerns these medical professionals had were around the protocol that they had been given to follow for treating patients with COVID-19. As they began to share their concerns, instead of the normal response from the FDA, CDC, or NIH to look into the challenges they were having, these doctors and nurses began having their licenses, their jobs, their practices, and their careers threatened, even though they were the professionals that spent every day working directly with the patients and advocating for their patient’s best interests.

Local Medical Professionals Speak Out

In researching this topic, a group of these healthcare professionals was found right here in North Carolina, and several of their practitioners were willing to speak to us. This group, the North Carolina Physicians for Freedom (NCPFF), is now comprised of nearly four hundred healthcare professionals that include cardiologists, anesthesiologists, virologists, pediatricians, internists, nurses, nurse practitioners, and many others. Their intent is to protect patient’s medical freedoms, privacy, and best healthcare options.

Staci Kay is a nurse practitioner who worked in an intensive care unit (ICU). In an interview, Kay shared her experiences working with COVID patients both inside and outside of the hospital, with two completely different outcomes.

Inside the Hospital with the NIH Protocol

The NIH protocol starts patients admitted with COVID-19 with the drugs Remdesivir and Dexamethasone. This is for patients who are on light oxygen. Staci Kay said that by the time they got to her in the ICU, they were already needing quite a bit of oxygen.

The next step as the condition worsens is to be put on bipap, which is a non-invasive breathing support administered through a face mask. Kay said, “When you have somebody who can’t tolerate being off the bipap for very long, and they’re doing this for several days at a time, they’re not getting nutrition, and they usually can’t take meds very well, so that’s when you think about intubation, because then you can at least put a tube down and get the medication that way.” That is when people are put on ventilators.

With COVID, that was extremely difficult. Kay explained, “Your lungs are like balloons, but with COVID, the lungs were like cement. So we’re throwing a bunch of oxygen at a very high pressure, but the lungs don’t have any give. That creates trauma in the lung field. The ventilator was the final step once they got that bad.”

With any other illness, if the protocol isn’t working, healthcare teams can usually reassess and try another treatment, but Kay said, “With COVID, we weren’t allowed to do that. There was a point when I actually asked our pulmonary critical care director if we could do the math plus protocol from FLCCC (Front Line Covid Critical Care), and he was like, ‘No. We’re not allowed to do any other protocols.’”


A local Asheville oncology nurse, who prefers to remain anonymous, said she was so excited when Anthony Fauci stated that Remdesivir was proven to work for COVID in the Ebola trials. She thought, “Finally, some help. Thank God,” but then she learned that Remedesivir, according to the Ebola trials study, had to be discontinued because 53% of the patients died. She stated, “When I found out he had lied, I was so angry!”

Outpatient Treatment Using the FLCCC Protocols

Nurse practitioner Staci Kay left the hospital to work with patients in an outpatient setting. When asked why, she simply said, “I got tired of watching people die.” It was also the time when healthcare professionals were being forced to choose between getting the vaccine or losing their jobs. Kay said, “What a horrible thing to do to people who have already spent over a year taking care of COVID patients. Once the mandates came out, I knew it was probably a matter of time before they were going to fire me for refusing the vaccine, so I just started treating people. I just thought, well, if I can’t treat them when they get here, maybe I can keep them from getting here. That’s how that evolved.”

Kay continued working in the hospital for a time but also worked doing telehealth, a service where your health care provider cares for you primarily online. This was when Kay saw what a difference early treatment and the FLCCC protocols could really make. “The outpatient therapy—gosh, if you could get people early enough, they were incredibly successful,” shared Kay. At the time of the interview, Kay said, “To date, I’ve treated close to 800 patients, and out of those 800, I believe, not more than ten have had to go to the hospital. It’s really awesome. And of the ones that did go, I know one of them had a complication. That couldn’t really be helped, but the other patients that had to go to the hospital all contacted me, like on day seven or later. Of the ten, there were only three people I know of who died.” In addition to helping people stay out of the hospital, Kay is also working with vaccine-injured people. She said, “I put all of my vaccine-injury people on Ivermectin; that’s number one. If they’re not willing to do that, then I can’t help them, because then the rest is just band aids, not going to help.”

Having seen how well her patients are doing on the FLCCC protocols, Kay now has a full-time telehealth practice, keeping even more people from ever going to the hospital. To view the FLCCC protocol and review studies on Ivermectin go to: